Evidence has been presented which proves that dibenzanthracene is metabolized by the mouse into at least four substances, and some specUlations as to the sites of this degradation have been advanced.
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In the accompanying paper (2) studies of the distribution of radioactivity following the administration of dibenzanthracene labeled in the 9 and 10 positions with carbon fourteen have been described. In contrast to all earlier reports, a virtually quantitative recovery of the dose administered has been accomplished. This is due to the fact that all substances derived from the carcinogen and still containi~g the labeled carbon atoms may be traced by following tr'e rad i oactivi ty, whereas the spectroscopio or fluorometric methods of ana lysis previously used are capable of directly detecting only those metabolites which maintain the intact pentacyclic aromatio ring system. This non-quantitative ----------,----"--_. ._,.~-,--, ---- recovery of carcinogen, and apparent disappearance have always been interpreted (3) as being due to metabolio degradation of the compound to other substances with non-characteristic absorption spectra or fluorescence. Levi and Boyland (4) in 1937 reported the isolation of a dihydroxydibenza~thracene from rabbit urine, and Dobriner, Rhoads and Lavin (5), in an extremely thorough study of the excreta of various animals given dibe~zanthracene subcutaneously, isola ted another oompound from Ue urine and feces of rats and mice, which was proved to be 4',8'-dihydroxydibenza~thraoene. In spite of a very extensive f.ractionation of excreta, bile, intestinal contents and whole mice, these investigators were unable to detec~any absorption spec~ra that appeared to be derived from the administered dibenzanthracene. Yet only a small peroentage of the original material could be accoun~ed~0~.
It was deoided to reinvestigate the problem of metabolic degradation uoing the radioactive carcinogen. Since it has been shown (2) that mQst of the radioaotivity is found in the excreta, a systematic study was undertQken in order to gain some i~fo~ation as to the types of substances produced as degradation nroducts, and to contrast and oompare the patterns of metabolism of the dibenzanthraoene when administered by different routes. Accordingly, we have submitted to chemical fractionation urines, feces, blles, subcutaneous injection sites, and tumors produced by tre labeled carcinogen. In these frae· tionations the radioactivity was determined in each step, and it was shown immediately that the compound is degraded to several substances, some highlỹ Berenblum and L. P. Ke~dall, biochem. J. 30, 429 (1936) .
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water-soluble, which are chemically very different from the original material, and must involve some deep-seated changes in the molecule. It is not surprising then, that spectroscopio methods failed to detect these substances, for even if new bands were obsorvGd there could be no definite demonstration that trese originated from metabolites of dibenzanthracene.
vvatGr··soluble derivatives of dibenzanthracene have been reported as having been obtained by photochemical oxidation of the compound in benzene solution. Boyland and Boyland (6) in 1934 studied the effect of these substances on various enzyme systems and J.lsopp and &zigeti (7) have determined their ahsorption spectra and tested tr'em for carcinogenicity. ,ve have found tr'at the prod.ucts of photooxidation of dibenz&ntr:racene are different from the water-soluble materials produced by metabolism in the mouse.
Experimental Methods
In order to compare the type and extent of metabolic degradation of dibenzanthracene following various modes of admintstration to mice, th0se samples have been collected: feces. urine, and bile from animals given the carcinogen intravenously as an aqueous colloid and intraperitoneally in tricaprylin; feces and urine after stomach tube administration in tricaprylin;
feces and injection sites folloWing subcutaneous injection in tricaprylin;
and tumors induced by the labeled dibenzanthracene. The bi.le samples were collected through one day, and'the total urine and feces. three days after administration. These specimens were then subjected to the extraction procedure shown in Table 1 .
The feces were dried at 70°in vacuum, were ground to a fine powder, ai.1d the radi.oactivity was determined after combusion of an aliquot as de- little dilute sodium hydroxide was added to tre remainder, and the water was removed as the azeotrope during the prolonged benzene extraction. Biles were evaporated to dryness after an aliquot was plated directly and a trace of alkali added. Injection sites and tumors were homOgenized, and the activity was determined by combustion of a sample. A little alkali was added, and the water was removed as the azeotrope during the benzene extraction.
The liquid-solid extractions were carried out in small flasks fitted with reflux condensers; the liqUid-liquid extractions were performed e':1tirely in centrifuge tubes, the upper layer being removed with a pipette. The radioactivity of both fractions was determined in all cases, so that a constant check was mai.ntained on total quantities, and losses might be spotted immedi-
Moreover, this procedure furnished partition coefficients for each step, information very valuable for attempts at complete chemical identificationa.
The radioactivities of solid samples were determined after combustions, as described previously (2). Liquid samples were plated directly (8) Table II . These are expressed as counts per minute and as percentage of the radioactivity in the original sample. The total counts recovered are also expressed as the number of milligrams of dibenzanthracene to which the radioactivity would be equivalent. It is quite evident from casual inspection of these data that dibenzanthracene is very extensively metabolized by the mouse to other substances differing Widely in chemical characteristics from the original carcinogen. However, in cr der to gain more detailed information as to the chemistry of the various fractions, each was subjected to further examination.
The dibenzanthracene is determined by means of carrier technique. A known amount of non-labeled dibenzanthracene is added during the fractionation and is crystallized from the benzene solution. It is purified by two recrystallizations, one from acetic a.cid, and the other from benzene. The dibenzanthracene is combusted and its radioactivity determined. Under these conditions this radioactivity could only originate from tre labeled carcinogen, and this furnishes an extremely accurate and sensitive method for the quanti- 
(mg. of (2) does not remove mare activity, indicating that no phenolic compounds are present in this mixture. I!'urthermore, it was found that there was a very considerable amount of actiVity present in this fr~ction~hut is not extracted with acid or alkali. This neutral material is not dibenzanthracene. for no radioaotivity was found in carrier dibenzanthracene added to the solution. This material is eVidently some neutral metabolite that was not taken up in the original benzene extraction.
In order to detect dihydroxydibenzanthracene with more certainty, the experiment shown in Tables I and II . Fraction D contains tre substances that were conjugated with solubilizing groups, and is acidic in nature, for most of the activity is extracted from the ethyl acetate by alkaline solution. The radioaotivity of Fraction E is in truly water-soluble form, even after rather drastic hydrolytic treatment. This activity is not extracted by 6thyl acetate from the aqueous phase at acidic, basic pH's or at neutrality. Fraction F is a solid that appears after hydrolysis and carries considerable activity.
The solid must be a component of the urine or feces, since several milligrams of material are invariably obtained whereas the radioaotivity it carries generally corresponds to only a few micrograms of oompoundo The solid is usually soluble in alkali, as is the radioactivity, but this varies from sample to sample, and little progress has been made as yet in the separation of the radioactive compounds from this solid carrier. 'l'hus, the chemical nature of~t his fraction is not clearly known, although it appears to be acidic, and yet formed on acidification of the original solution partially dissolved in alkali, and on acidification of an appreciable amount of radioactivity was extracted by ethyl acetate.
Fraction I
In some samples there was still radioactivity in the residue from the a~_l.caline extraction, Fract: O~l fi" vihen this residue was refluxed with dilute sulfuric acid, no a0tivity u;:lIJE\'J.red in the aqueous phe.se. H01ABver, when the rBsidue was then extracted w::.th alkali, rad;_oactivity appeared in the aqueous 301 uti on. This activity rep:coeser-ts acidlc compounds that are possibly conju-,,:E\-t;ed with protein or other materis.l in such a way that they are hydrolyzed by acid and not by base. Table VII At the kind suggestion of Lr. Jumes Cason, who called our attention t·.) the fact that dihydroxydibenzanthr&cene is very unstable in acidic solution, the experiment shown in Table VII was carried out in order to determine whetheT some of the "metabolites ll encountered in tre previously described work might have ari'lsen from the nhenolic compound as an !.. rtifact during the isolation procedure.
The feces sample was acety1f;,ted before further processing in order to protect any dihydroxydibenzanthracene that might be present, and the mixture was extracted with ethyl acetate, Fraction 1. This was then hydrolyzed with alkali, and re-extracted with ethyl acetate. Carrier dibenzanthracene was added to this fraotion and after nurifica tion, it was found that 6.5% of the activity was due to the unchanged carcinogen. This represents 1.6 ?fof C"O'!Tlpound. F'r~ction 2 was acidified and extructed with et!1yl aceta te, and Fraction there is immedia~e uptake of activity by the liver whicl-then empties i t int., the bile. &inoe it has also been demonstrated that the only source of activitỹ~i n the intestinal contents is derived from the bile, it is evident that further degradation takes pl&ce in the intestinal tract, because of the considerably , I
UCRL-45 sma lIer quantity of non-metabolized carcinogen in the feces than in the bile.
It is rather surprising that such u large and insoluble molecule could be e1im-inated through the kidneys.and anpeur in the urine, but similar observations have been made by spectroscopic methods (3c). It is possible, however, that this may have arisen due to contamination of the urine by the feces, since it was impossible under the conditions of our experiments to prevent these excreta from coming into contact with each other. The B fraction contai.ns considerably more activity in the urine and feces than does the bile. The absence of an H fraction in the bile probably indicates only that the metabolite does not conjugate with the components of the bile.
Stoma ch Tube
There is a considerably larger amount of unchanged dibenzanthracene in the feces (45%) by this route than by Ue others, but only 4.5% of the radioactivity in the urine sample can be accounted for as dibenzantrrucene. This probably indicates that the intestinal tract is not as efficient as the liver in metabolizing the compound. '1'ne majority of the w[~ter soluble material in the feces is bound in some way (Fraction H), whereas in the urine most of the activity appears in Fraction C and is in a less conjugated state. However, the degrade.-tion in these oases must take place exolusively in the gastrointestinal tract.
IntraperitoT here is very extensive metabolism of dibenzanthracene admi.nistered intra- Table VII (2) .) There appears to be a considerable individual vhriation among these. In three of the tumors more than 90% of the radioactivi ty is due to unch[~nged dibenzanthracene. rowever, it is striking that in two of the tumors, the carcinogen has been extensively degraded (only 15% and 54% of the activity is due to dibenzanthracene). Since
.there is no evidence that under normal conditions any degradation occurs at t:re site of subcutaneous injection, these results suggest that neoplastic tissue is capable of degrading the carcinogen, whereas normal tissue ca'1Uot. Obviously, more experiments must be done before this point can be settled with certainty.
Photooxidation of dibe~zanthracene -''HI
Labeled dibenzanthracene was photooxidized in benzene solution by exposure ror one hour to a mercury vapor are, &ccording to the procedure of Alsopp and ted. There is also an appreciable loss of overall activity when alkaline solutions are concentrated at atmospheric pressure, suggesting perhaps that volati Ie neutra 1 substances are formed during Ue reaction. These observations suffice to prove that the water·soluble metabolites are not closely related to the photooxidation products, because Ue former never exhibit this instability.
Discussion of Results
In the preceding sections of this paper, evi.dence has been presented which proves the,t dibeuanthracene is metabolized by tloe mouse into at least four substances, and some speculations as to the sites of this degradation have been advanced. it is possible that a small e.mount of these compounds is produced as an artifcat from dihydroxydibenzanthracene during the isolation procedure.
The fact that unchanged dibenzanthracene is found in tumors six to eight months after their induction is an interesting one, and loas previously been demonstrated spectrophotometrically by Lorenz and Shear (10). This observa· tion, i t must be emphasized, does not throw any light on the problem as to whether the original hydrocarbon is tre true carcinogen, or whether some meta· bolite is. In view of the increasing body of evidence (11) UCRL-45 irreversible process that leads to the tumor, the fact that appreciable amounts of dibenzanthrace~e are found in the tumor is of little more than academic interest. Indeed, it seems likely that the metabolic degradatlon described here is merely a detoxication process quite unrelated to the initiation of This work is being continued with the aim of elucidation of the structures of these metabolites, and the various fractions described are being tested both for caroinogenic and tumor-regressive properti.es.
